Objective: The objective of the present study is to identify novel, time-indexed imaging biomarkers of epileptogenesis in mesial temporal lobe epilepsy (MTLE). Methods: We used high-resolution brain diffusion tensor imaging (DTI) of the translationally relevant methionine sulfoximine (MSO) brain infusion model of MTLE. MSO inhibits astroglial glutamine synthetase, which is deficient in the epileptogenic hippocampal formation of patients with MTLE. MSO-infused (epileptogenic) rats were compared with phosphate-buffered saline (PBS)-infused (nonepileptogenic) rats at early (3-4 days) and late (6-9 weeks) time points during epileptogenesis. Results: The epileptogenic rats exhibited significant changes in DTI-measured fractional anisotropy (FA) in numerous brain regions versus nonepileptogenic rats. Changes included decreases and increases in FA in regions such as the entorhinal-hippocampal area, amygdala, corpus callosum, thalamus, striatum, accumbens, and neocortex. The FA changes evolved over time as animals transitioned from early to late epileptogenesis. For example, some areas with significant decreases in FA early in epileptogenesis changed to significant increases late in epileptogenesis. Finally, the FA changes significantly correlated with the seizure load. Significance: Our results suggest (1) that high-resolution DTI can be used for early identification and tracking of the epileptogenic process in MTLE, and (2) that the process identified by DTI is present in multiple brain areas, even though infusion of MSO is restricted to the unilateral entorhinal-hippocampal region.
Epileptogenesis is the clinically silent, pathologic process that underlies the development of epilepsy after an insult to the brain. It is believed that halting this process can prevent epilepsy from becoming manifest. However, no antiepileptogenic interventions are available for human use because we do not know when and what to treat. Early identification of epileptogenesis, using sufficiently sensitive and specific biomarkers, is critical because it will define which patients to treat, thus reducing the risks and expenses associated with poorly targeted, population treatments. Such biomarkers can also be used to monitor the efficacy of treatments and to obtain information about disease mechanisms and therapeutic targets.
However, identification of biomarkers for human use has been challenging due to the long period of epileptogenesis and low incidence of epilepsy after an insult to the brain. Although animal models may not be associated with these limitations, no animal-derived biomarker has yet been translated to human use. A possible reason for the poor translational yield is that many animal models do not recapitulate key aspects of human epilepsy, thereby limiting the utility of these models for biomarker investigations. 1 We recently developed an effective and translationally relevant model of mesial temporal lobe epilepsy (MTLE) by inhibiting the astroglial enzyme glutamine synthetase (GS) in the entorhinal-hippocampal-amygdala territory of rats. A continuous infusion of the GS inhibitor methionine sulfoximine (MSO) into this territory results in an initial episode of seizures, a clinically silent latent period of approximately 1 week, recurrent seizures that increase in severity over weeks, and depressive-like behaviors. 2, 3 Thus the MSO paradigm replicates several features of human MTLE, such as an initial (seizure) insult, 4 a latent period, 5 loss of GS, 6, 7 progressive worsening of seizures, 8 and comorbid depression. 9 The MSO infusion causes brain pathologies similar to those of human MTLE, such as hippocampal neuron loss 3 and changes in brain monocarboxylate transporters. 10 The mortality is <2% with >80% of rats exhibiting recurrent seizures. 3 Thus the MSO model is particularly well suited for studies of biomarkers in MTLE.
Low magnetic field (1.5 T) brain diffusion tensor imaging (DTI) and diffusion-weighted imaging (DWI) show changes in humans with fully developed MTLE versus nonepileptic subjects. 11 However, it is not known whether DTI/DWI can be used for early detection of the epileptogenic process. Here we asked the question whether high magnetic field (9.4 T) ex vivo DTI can be used for monitoring the epileptogenic process in the MSO model of MTLE. Epileptic (MSO-infused) and nonepileptic (phosphate-buffered saline [PBS]-infused) rats were imaged early in epileptogenesis (3-4 days after start of infusion) and late in epileptogenesis (6-9 weeks after start of infusion). The DTI studies were correlated with video intracranial electroencephalography (EEG) analyses and histopathology.
Materials and Methods

Animal model
Male Sprague-Dawley rats (370-430 g) were implanted with a cannula into the right entorhinal-hippocampal region for continuous infusion of either MSO (n = 18) or PBS (n = 13) as detailed in Dhaher et al. 12 Epidural screw electrodes were implanted in the skull to record cortical EEG activity.
EEG
EEG monitoring was performed after awakening from surgery to day 4 for the early stage group and during the fourth and fifth weeks postsurgery in the late group. The video-EEG record was analyzed for frequency and duration of seizures. Seizure severity was established using a modified Racine scale as detailed in Racine et al. 13 One hour interictal EEG epochs at least 12 h from a seizure were selected for spectral analysis. The total power and power in the standard delta, theta, alpha, beta and gamma frequency bands was obtained using a Fourier power spectral density estimator. EEG recordings were compared using a twosided Student's t-test with significance set at 0.05. Power estimates were normalized to standard Z-scores prior to statistical tests.
Fixation
Rats were perfusion fixed with 4% formaldehyde in PBS, 4 days following surgery in the early stage group, and 6-9 weeks following surgery in the late-stage group. Brains were postfixed for 21-28 days at 4°C before imaging.
Imaging
The fixed brains were rinsed in PBS and placed into a custom-built magnetic resonance imaging (MRI)-compatible tube filled with Fluorinert (Sigma-Aldrich, Inc. St. Louis, MO, U.S.A.). MRI was performed on a 9.4 T horizontal bore magnet (Bruker, Billerica, MA, U.S.A.) with custom-made 1 H radiofrequency coils (14 mm diameter).
14 Coronal slices of 800 lm thickness were acquired for both anatomic and DTI images. Anatomic images were acquired using a spin-echo sequence with repetition time (TR) of 3,000 msec and an echo time (TE) of 10 msec, with a maximum of 16 averages with an in-plane resolution of 100 lm 9 100 lm. DTI acquisition followed the StejskalTanner spin-echo diffusion-weighted sequence with a diffusion gradient d = 5 msec and a delay D = 15 msec between diffusion gradients. 15 TR was 2,000 msec and TE was 25.1 msec. Two Shinnar-Le Roux (SLR) pulses of 1 msec each were used for excitation and inversion. Data for each slice were acquired with a 12 9 64 matrix and then zerofilled to 256 9 256. A total of 16 different noncollinear diffusion-weighted directions were acquired with the same b = 1,000 s/mm 2 . Previous studies comparing fixed versus in vivo DTI have shown no significant differences in DTI parameters. [16] [17] [18] Imaging data analysis
The six elements of the diffusion tensor were calculated from the signal intensity of the 16 diffusion-weighted images. Tensor eigenvalues k 1 , k 2 , k 3 and their corresponding eigenvectors were found by matrix diagonalization. images and Gaussian smoothing (full width at half maximum [FWHM] = 0.47 mm) were performed as described previously. 14 Regions of interests were selected without a priori knowledge using voxel-based clustered t-test comparisons. T-maps were generated using a two-sample t-test with a significance p < 0.05 and a cluster size of 200 for both. The t-maps were then used to mask the averaged FA difference (MSO-PBS) and overlaid on an anatomic average of the rat brains to visually identify areas of significant change based on the standard rat brain atlas. 19 The same process was repeated for anatomic and MD differences between MSO treated and PBS rats, both for early and late stages of epileptogenesis.
Regions of interest (ROIs) were manually outlined based on the masked FA difference maps and then applied across registered individual brains for group analysis to compare regional averages for the registered FA, k ⊥ , and k || maps. Statistical significance for these ROIs was computed using multiple t-tests with Holm-Sidak correction for multiple comparisons.
Average directionally encoded color (DEC) maps for each group were generated by averaging the six components of the diffusion tensor from each animal. Additional details can be found in Appendix S1.
Seizure load versus FA
FA values in the dorsal hippocampus, ventral hippocampus, and thalamus of individual early stage MSO and PBS animals were evaluated early during epileptogenesis to both test if they were impacted by the seizure load in the MSO animals and if they could be used to distinguish MSO and PBS animals. These regions were selected based on their frequent implication in various animal model and human studies. A triplet of values, consisting of the FA values for the ventral hippocampus, dorsal hippocampus, and thalamus was formed for each animal and plotted. The animals then underwent an automatic classification procedure, and the separation of the two groups of animals was tested statistically using a k-means classifier and the leave-one-out method. We next sought to understand if FA changes observed in the MSO animals were related to the seizures that had been experienced by these animals. We first calculated, separately for the MSO and PBS animals, the centroid of the triplet of FA values. Next, we plotted the total time under seizure (seizure load) for the MSO animals, first as a function of distance of each animal to the centroid of the data for the MSO animals and second as a function of distance to the centroid of the data for the PBS animals.
Results
Seizures
The frequency and behavioral classification of seizures during early epileptogenesis are summarized in Figure S1A .
All of the MSO-infused animals and none of the PBSinfused animals exhibited recurrent seizures. The average frequency of seizures was 3.2 per day with peak frequency on days 1 and 2. Most seizures were Racine stage 1 (75% of all seizures), followed in declining frequency by: subclinical (9%), stage 3 (8%), stage 2 (7%), stage 4 (1%), and stage 5 (0%; see Fig. S1C for an example of a seizure).
The frequency and behavioral classification of seizures during late epileptogenesis are summarized in Figure S1B . All of the MSO-infused animals and none of the PBS-infused animals exhibited recurrent seizures. The average frequency of seizures was 0.56 per day. Most seizures were stage 5 (78% of all seizures), followed in declining frequency by stage 4 (9%), stage 3 (7%), subclinical (4%), stage 1 (2%), stage 2 (0%; see Fig. S1D for an example of a seizure).
EEG spectral analysis
No changes in EEG band power were found in the contralateral hemisphere between MSO animals and their PBS controls at either the early or the late stage of epileptogenesis. In the ipsilateral hemisphere, delta band power was significantly greater in MSO than PBS animals at the late stage (p = 0.046; Fig. S1E ,F).
Fractional anisotropy (FA) differences by DTI
The averaged anatomic images of MSO-infused and PBS-infused animals at early and late stages of epileptogenesis exhibited no significant structural differences between groups; only a small tract indicated the infusion cannula (Fig. 1A) . Figure 1B shows differences in FA that were present at early and late stages of epileptogenesis in MSOinfused versus PBS-infused rats. Although infusion of MSO was localized in the right entorhinal cortex, significant differences in FA were present in numerous brain regions in the contralateral hemisphere, including areas far from the infusion site. FA differences were found in both gray and white matter structures. In the early stage, 42 areas of significant differences between MSO-infused and PBS-infused rats were initially identified and then grouped into 15 ROIs (Fig. 2 ). In the late stage, 34 areas of significant differences were initially identified, and then grouped into 13 ROIs (Fig. 3 ).
Seizure load versus DTI
Plotting individual FA values for ventral hippocampus, dorsal hippocampus, and thalamus on separate axes revealed clustering of the MSO and PBS animals into two groups, and a separation between MSO-infused and PBSinfused animals at the early stage (Fig. 4A ). The triplets of FA values (ventral hippocampus, dorsal hippocampus, thalamus) from the 12 animals (six PBS and six MSO) were categorized with a k-means classifier using the leave-oneout method. Perfect classification was achieved in all 12 tests with the leave one-out method There was a decreasing trend of seizure load as a function of distance to the centroid Epilepsia, 58 (5) (Fig. 4B ). There was an increasing trend with seizure load as a function of distance to the centroid of the PBS values (Fig. 4C ). The trends displayed were determined by a fit of a sum of two exponentials to the data. We note, though, that the trend displayed is supported by multiple data points, the curves fitted to the data in Figures 4B,C may be influenced by one extreme data point, so only limited conclusions can be drawn from the analysis presented here.
FA differences during early epileptogenesis
In early epileptogenesis, increases in FA were preferentially observed in ventral and central portions of the brain, whereas decreases in FA were observed mainly in dorsal and peripheral (neocortical) areas (Fig. 2B and Table S1 ). The most pronounced increases in FA were observed in the following gray matter areas (the most changed listed first): ventral hippocampal formation (dentate gyrus, CA3 and subiculum) > entorhinal cortex > accumbens shell > brainstem > thalamus (ventral, central, and posterior nuclei) > insular cortex > hypothalamus > subthalamus > olfactory structures (piriform, olfactory tubercles, and endopiriform). Most increases were present bilaterally. Ipsilateral-only increases were seen in the dorsal endopiriform nucleus, granular/dysgranular insular cortex, ventral CA3, and ventral dentate gyrus. Contralateral-only increases were evident in the ventral subiculum and piriform cortex. White matter increases included a small area (~0.5 mm 3 ) of the posterior corpus callosum.
The most pronounced gray matter decreases in FA were seen in amygdala (central and medial) > dorsal hippocampus (dentate gyrus, CA1, subiculum) > various cortical areas (anterior, posterior, somatosensory, prelimbic, temporal association, visual, ectorhinal, perirhinal, piriform > striatum (globus pallidus and caudate putamen). Most decreases were present bilaterally. Ipsilateral-only decreases were evident in piriform cortex, central amygdala, and visual cortex. Contralateral-only decreases were evident in dorsal subiculum and subiculum transition area. The internal capsule was the only white matter area with decreased FA.
FA differences during late epileptogenesis
In late epileptogenesis, increases in FA extended from ventral and central portions of the brain to also include dorsal and peripheral areas (Fig. 3B) . Several areas showed marked differences in FA from early to late epileptogenesis. The most pronounced changes were observed in the amygdala (decrease to increase), ipsilateral dentate gyrus (decrease to increase), and several white matter areas (mild increase to marked increase).
The most pronounced gray matter increases in FA in MSO-infused versus PBS-infused rats at the late stage were observed in: hippocampus (dentate gyrus) > entorhinal cortex > subthalamus > posterior cortex (ectorhinal/perirhinal) > thalamus (ventral, geniculate, and reuniens nuclei) > piriform cortex. White matter increases included the corpus callosum and mammillothalamic tract. Increases DEn, dorsal endopiriform; AcbSh, accumbens shell; GI/DI-I, granular/dysgranular insular cortex-ipsilateral; CPu, caudate putamen; GP, globus pallidus; Cg, cingulate cortex; S1, primary somatosensory cortex; S2, secondary somatosensory cortex; C-Pir-C, central piriform cortex-contralateral; Pir-I, piriform cortex-ipsilateral; PLCo, posterolateral cortical amygdala; ic, internal capsule; MeA, medial amygdala; CeA-I, central amygdala-ipsilateral; C/M Thal, central/medial thalamus; VThal, ventral thalamus; DG-D, dentate gyrus-dorsal; CA1, CA1 of the hippocampus; ZI, zona incerta; P-Pir-C, posterior piriform cortex-contralateral; PLH, peduncular part of the lateral hypothalamus; VPPC, ventral posterior nucleus of the thalamus, parvicellular part; VS-C, ventral subiculum-contralateral; Po, posterior thalamus; SNR, substantia nigra; DLEnt-C, dorsolateral entorhinal cortex-contralateral; PIL, posterior intralaminar thalamic nucleus; PAG, periaqueductal gray; Rt, reticular formation; cc, corpus callosum; CA3-I, CA3 of the hippocampus-ipsilateral; DG-I-V, dentate gyrus-ipsilateral-ventral; APir, amygdalopiriform transition area; TeA-C, temporal association cortex-contralateral; STr-C, subiculum transition area-contralateral; DS-C, dorsal subiculum-contralateral; M/CEnt-medial/caudomedial entorhinal cortex; V-I, visual cortex-ipsilateral; Ect/Prh, ectorhinal/perirhinal cortex. Early Stage Grouped FA differences, arranged from anterior to posterior (gray matter) with white matter changes on the right (bottom, B). Regions with an x superscript consist of mixed FA increases and decreases. Statistical significance was determined using multiple t-tests with Holm-Sidak correction for multiple comparisons. Asterisks indicate levels of significance where *p < 0.05, **p < 0.01, ***p < 0.001. Epilepsia Representative slices from anterior to posterior of FA differences (p < 0.05) between MSO-treated and PBS-treated rats at the late stage (top, A). Warm colors represent increases in FA, whereas cool colors represent decreases in FA. Abbreviations are as follows: LO-I, lateral orbital cortex; S1, primary somatosensory cortex; Tu 1,2,3, olfactory tubercles 1,2,3; CPu, caudate putamen; LAcbSh, lateral accumbens shell; Pir-C, piriform cortex-contralateral; MnPo, median preoptic nucleus; MCPO, magnocellular preoptic nucleus; GP, globus pallidus; Pir-I, piriform cortex-ipsilateral; cc, corpus callosum; Re, reuniens; Amyg-C, amygdala-contralateral; DEn, dorsal endopiriform; AThal, anterior thalamus; BL-I, basolateral amygdala-ipsilateral; MDM/MDL, mediodorsal thalamus, medial/lateral; Po, posterior thalamus; VThal, ventral thalamus; PLH, peduncular part of the lateral hypothalamus; DG-I, dentate gyrus-ipsilateral; mt, mammillothalamic tract; PLCo, posterolateral cortical amygdala; CThal, central thalamus; LThal, lateral thalamus; ZI, zona incerta; DLG, dorsal lateral geniculate; VPPC, ventral posterior nucleus of the thalamus parvicellular part; CA1-C, CA1 of the hippocampus-contralateral; MG/VG, medial/ventral geniculate nucleus; Ent-I, entorhinal cortex-ipsilateral; Ect/PRh-I, ectorhinal/perirhinal cortex-ipsilateral; TeA-I, temporal association cortex-ipsilateral; Ect/PRh-C, ectorhinal/perirhinal cortex-contralateral. Late Stage Grouped FA differences, arranged from anterior to posterior (gray matter) with white matter changes on the right (bottom, B). Regions with an x superscript consist of mixed FA increases and decreases. Statistical significance was determined using multiple t-tests with Holm-Sidak correction for multiple comparisons. Asterisks indicate levels of significance where *p < 0.05, **p < 0.01, ***p < 0.001. Epilepsia in FA in the thalamus, white matter, amygdala, and subthalamus were primarily bilateral. In the dentate gyrus and entorhinal cortex, increases were localized to the ipsilateral hemisphere. In the piriform cortex and the ectorhinal/ perirhinal cortex, increases were localized to the contralateral hemisphere. Although increases in FA in amygdala and lateral hypothalamus were noted by clustered voxel analysis, the differences did not reach statistical significance upon further testing. The most pronounced gray matter decreases in FA in MSO-infused versus PBS-infused rats at the late stage were observed in posterior cortex (ectorhinal/perirhinal and temporal association) > olfactory tubercles > striatum (caudate putamen and globus pallidus) > accumbens shell > somatosensory cortex > preoptic nucleus > CA1. Decreases in FA were bilateral in the somatosensory cortex, basal ganglia, olfactory tubercles, and preoptic nucleus. Ipsilateral decreases were localized in the piriform cortex, and the posterior cortex.
Areas such as the olfactory structures (piriform, olfactory tubercles, and endopiriform) and hypothalamus (striatum, accumbens) had a mixture of both increases and decreases in FA, and thus did not reach significance when grouped. Regions of FA abnormalities that are common in the early and late stages include corpus callosum, hippocampus, thalamus, amygdala, posterior cortex, somatosensory cortex, and olfactory cortex (see Tables S1 and S2) .
FA-derived network differences
Several regions that were identified in the early stage as showing differences in FA between MSO-infused and PBSinfused rats, continued to show changes in the same locations through the late stage. Although the magnitude and direction of change were similar, the volume of significant FA change, as seen in Figure 5 , differed by more than twofold in some areas. In the basal ganglia, somatosensory cortex, white matter, and thalamus, the volume of FA change was at least twofold higher in the late stage versus early stage groups. The olfactory structures and hippocampus demonstrated a decrease in area of change at the late stage compared to the early stage, although the magnitude was not as large as the increases. The early stage group also demonstrated changes in anterior (anterior cortex, insular cortex) and posterior (brainstem, substantia nigra) regions. These changes were not evident at the late stage. Figure 6 summarizes the differences in anteroposterior (AP), mediolateral (ML), and dorsoventral (DV) directionality in each clustered ROI between MSO-infused and PBSinfused animals in both early and late-stage groups. No change in a specific axis was found to be significantly different between MSO and PBS groups at each stage, indicating that most differences in FA were driven by a mixture of differences along all three axes rather than by a single axis of diffusion. However, there was a trend for changes along the AP direction to be the most dominant compared to other directions.
Differences in parallel and perpendicular diffusivity at both the early and late stages were overall unremarkable, with changes noted only in the amygdala and subthalamus. At the early stage, the amygdala had significant changes in perpendicular diffusivity (p < 0.05), whereas at the late stage, the subthalamus had significant changes (p < 0.05). No differences in parallel diffusivity were noted.
Differences in mean diffusivity between MSO and PBS animals at both the early and late stages were noted by voxel-based clustered t-test comparison. In the early stage, MD was primarily increased, especially in ventral cortical areas of the brain (Fig. S2A) . In the late stage, MD was increased in anterior, central areas, and then decreased in ventral, posterior parts of the brain (Fig. S2B) . In the late stage, this anterior to posterior patterning of MD is similar to the patterning seen in the late stage FA changes, where -axis) (middle, B) . Conversely, there is an increasing trend with seizure load (y-axis, in seconds) versus distance to the centroid of the PBS values (x-axis) (right, C). In B and C the y-axis ranges from 1,000 to 4,000 s. Epilepsia ILAE decreased FA is noted anterior, whereas increased FA is noted posterior.
Discussion
Using high-resolution ex vivo DTI we identified significant changes in FA in numerous brain regions in epileptogenic versus nonepileptogenic rats. The FA changes evolved over time as animals transitioned from early to late epileptogenesis, and the changes were correlated significantly with seizure load.
Even though DTI or DWI have not been implemented for prospective studies of epileptogenesis in humans, such imaging has been used extensively in patients with fully established MTLE for disease classification, 11 seizure localization, 20 surgery refinement, 21 seizure network assessments, 22 and prognostication. 23 Only a few studies have used DTI or DWI during epileptogenesis in animal models of epilepsy. Parek et al. 24 found changes in FA in the hippocampus, amygdala, entorhinal cortex, piriform cortex, and thalamus in a limbic status epilepticus model of epileptogenesis. These changes were observed only in rats that developed spontaneous limbic seizures and were correlated with mossy fiber sprouting using Timm's staining. In another study of juvenile rats, 4 and 8 weeks after pilocarpine-induced status epilepticus, DTI abnormalities persisted for 8 weeks in the medial corpus callosum. 25 Time points earlier than 4 weeks were not investigated, and is it known whether animals with DTI changes developed spontaneous recurrent seizures. Thus the significance of these findings for epileptogenesis is uncertain. A third study of hyperthermic seizures in 9-day-old rats demonstrated DTI abnormalities that persisted for up to 8 weeks in the amygdala and hippocampus; however, it is not known whether the animals developed spontaneous recurrent seizures. 26 We demonstrated significant changes in FA in numerous white and gray matter areas both early and late in epileptogenesis. In contrast to most other epilepsy studies, the FA changes reported by us involved many brain regions, even though MSO was administered focally in the right entorhinal-hippocampal area. The widespread involvement by DTI cannot be explained by diffusion of MSO away from the Figure 5 . Volume of statistically significant region in early and late stage group animals. Late stage animals had a greater volume of significant difference in the basal ganglia, somatosensory cortex, and white matter compared to early stage animals. Conversely, the early stage group had a greater volume of significant differences in FA in the hippocampus and in the olfactory structure. In addition, very anterior and posterior regions such as the anterior cortex (prefrontal and cingulate) and brainstem exhibited significant FA differences between MSO-treated and PBS-treated animals in the early stage, whereas, no significant differences were found in these areas in the late stage. Epilepsia ILAE A Figure 6 . Directionally encoded color maps indicating differences in diffusion along the ML (red), DV (green), and AP (blue) axes between the MSO-treated and PBS-treated animals in both groups (top, A). Color intensity is proportional to the FA value. White arrows indicate key areas where differences can be seen. For the early stage group, arrows point to the dentate gyrus (DG) and thalamus (thal). For the late stage group, arrows point to differences in the corpus callosum (cc), dentate gyrus (DG), and thalamus (thal). Epilepsia ILAE infusion site because prior studies have revealed minimal, if any, effects of MSO on glutamine synthetase activity in areas other than the unilateral entorhinal-hippocampal area. 27 It is more likely that the effects are caused by activation of interconnected neuronal networks by the seizures. There is increasing acceptance that localization-related epilepsies depend on the activity of a network of functionally connected brain regions that act synergistically to generate and maintain seizures. 28 Our results are consistent with the emerging idea that MTLE is a disorder of widespread neuronal network activation, rather than highly localized (focal) seizure activity. The spatial extent of this network remains to be determined; however, in human MTLE, evidence suggests the involvement of large brain cortices, including the hippocampi, the amygdalae, the entorhinal cortices, lateral temporal neocortices, and extratemporal components of the medial thalamus and the inferior frontal lobes. 28 Another feature of our study was the extensive involvement of gray matter areas detected by DTI. Most prior studies using DTI and DWI in patients and animal models of epilepsy reveal changes preferentially in white matter structures, suggestive of axonal pathway alterations. 29 However, decreases in apparent diffusion coefficient (ADC) using DWI, or decreases in FA using DTI, are known to occur in gray matter areas during cerebral ischemia and sustained seizures. Such decreases are thought to reflect blood-brain barrier disruption with cytotoxic edema 30 and contraction of the extracellular space volume. 31 Intracellular cytoskeletal fragmentation with increased cellular tortuosity and viscosity may also contribute to the restricted diffusion. 32 Increases in FA in gray matter areas have been attributed to inflammation and gliosis where the infiltrating glial cells create a more directional water diffusion. 33 These changethat is, blood-brain barrier disruption, 34 cytotoxic edema, 35 extracellular space contraction, 36 cytoskeletal changes, 37 inflammation, 38 and gliosis 39 may occur in gray matter areas during epileptogenesis and therefore could be the underlying cause of the DTI changes observed in our model.
The low cluster-threshold used for ROI (cluster size >200) may induce false-positive findings. 40 However, although a voxelwise analysis is less sensitive to statistical assumptions, the cluster-based method provides a better separation of affected regions into several ROIs for additional immunohistochemical investigations. Moreover, the use of the same datasets for ROI selection and statistical analysis, commonly known as "double dipping," 41 represents a potential limitation of our data analysis. However, as mentioned earlier, additional immunohistochemical investigation of the selected ROIs were used to confirm the significance of the measured DTI changes.
We carried out a limited study of potential neuropathologic changes in one of the regions with the most significant change in FA, that is, the left and right dorsal hippocampal formation. Using immunohistochemical staining for astrocytes, microglial cells, and myelinated axons, we were unable to detect any significant differences between MSOinfused and PBS-treated rats (Fig. S3) . However, the negative results do not rule out specific cellular and molecular changes as being the causes of the observed FA alterations. To fully address this issue, more sensitive approaches are needed, such as increasing the number of brain area samples and implementing high-throughput screening approaches such as transcriptomics and proteomics. More extensive immunohistochemical, electron microscopy and Western blot studies should be considered as well.
Plotting individual FA values for ventral hippocampus, dorsal hippocampus, and thalamus on separate axes revealed a clear separation between PBS and MSO animals (Fig. 4A) , underscoring the considerable separation between the MSO and PBS animals at the early stage of epileptogenesis. Furthermore, a decreasing relationship was observed between the seizure load for the MSO animals and the FA centroid of the MSO animals, and an increasing relationship was observed between the seizure load for the MSO animals and the FA centroid of the PBS animals. These relationships suggest that with increasing seizure load the FA values for the MSO animals converge to a point that is representative for the MSO animals, and distinct from the centroid of values for the PBS animals. The results in Figure 4B ,C should be interpreted with caution because they can be influenced to a greater extent by the results of a single animal, and because of the low n-size and the inclusion of EEG results from the early time-point and not from the late time-point. Furthermore, although the animals were monitored continuously, there is a small chance that a seizure occurred between the time the animal was disconnected from the EEG equipment and the time it was euthanized. Thus the DTI results in one or more animals might have been impacted by an undetected seizure. However, it is unlikely that such a rare event would significantly change the group averages.
In summary, we have demonstrated that high-resolution DTI detects significant changes in several areas of the brain in the MSO-model of MTLE. Our results provide new insight into the anatomic extent and temporal evolution of structural changes in the brain after a highly focal epileptogenic insult. Future studies aimed at determining the cellular and molecular nature of the DTI changes, and thus the underlying mechanisms of epileptogenesis, are likely to be significant because such studies may facilitate the development of novel antiepileptogenic therapies. Our results clearly demonstrate the potential utility of highresolution DTI as a novel biomarker tool for detection and tracking of the epileptogenic process and noninvasively measuring seizure load at the early time-point during epileptogenesis. Additional studies are needed to determine the specificity and sensitivity of the DTI approach in this and other relevant models of post-lesional epilepsies. Similar investigations using in vivo DTI will also be necessary because this approach can be used in humans. 
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Appendix S1. Materials and methods. Figure S1 . Seizure frequency and severity at days 1-4 in the early stage MSO group (top, A) and at weeks 4-5 in the late stage MSO group (top, B). In both groups, none of the PBS animals had any seizures. Sample early stage MSO seizure, Racine stage 1 (middle, C) and sample late stage MSO seizure, Racine stage 5 (middle, D). Each row corresponds to 60 s. Z-scores of power analysis of 1-h background EEG epochs at both early and late stage in MSO animals normalized to control PBS animals (bottom, E and F respectively). Figure S2 . Representative slices from anterior to posterior of mean diffusivity (MD) differences (p < 0.05) between MSO-treated and PBS-treated rats at the early stage (A), and the late stage (B). Figure S3 . Paraffin sections from the dorsal hippocampus of PBS-and MSO-infused rats that were imaged early and late in epileptogenesis. Table S1 . Early Stage Grouped FA differences, arranged from anterior to posterior (gray matter) with white matter changes at the end. Table S2 . Late Stage Grouped FA differences, arranged from anterior to posterior (gray matter) with white matter changes at the end.
